Table 2.
HPLC-based measurements of global 5-methylcytosine content in normal and cancer DNA samples
| Sample | Laird ID | Normal/cancer | Global methylation: mC/(mC + C) (%) |
|---|---|---|---|
| WT4 | 6027 | Cancer | 2.88 |
| OvCa E | 6020 | Cancer | 2.94 |
| WT31 | 6036 | Cancer | 2.94 |
| WT9 | 6030 | Cancer | 3.09 |
| OvCa I | 6021 | Cancer | 3.11 |
| WT14B | 6031 | Cancer | 3.18 |
| WT6 | 6028 | Cancer | 3.20 |
| WT29 | 6035 | Cancer | 3.25 |
| OvCa L | 6023 | Cancer | 3.27 |
| WT7A | 6029 | Cancer | 3.28 |
| WT24 | 6033 | Cancer | 3.28 |
| OvCa D | 6019 | Cancer | 3.31 |
| WT22 | 6032 | Cancer | 3.39 |
| WT 27 | 6034 | Cancer | 3.46 |
| OvCa B | 6018 | Cancer | 3.48 |
| Liver A | 6042 | Normal | 3.55 |
| OvCa J | 6022 | Cancer | 3.56 |
| OvCa Q | 6026 | Cancer | 3.57 |
| OvCa M | 6024 | Cancer | 3.61 |
| Lung C | 6046 | Normal | 3.68 |
| OvCa O | 6025 | Cancer | 3.73 |
| OvCa A | 6017 | Cancer | 3.76 |
| Kidney B | 6043 | Normal | 3.77 |
| Spleen C | 6045 | Normal | 3.77 |
| Thyroid B | 6044 | Normal | 3.77 |
| Cerebellum A | 6041 | Normal | 4.26 |